Antitrust regulators from the Justice Department have been wary of the $20 billion deal between Anheuser-Busch InBev and Mexican brewer Grupo Modelo. The deal would give beer giant A-B InBev ownership of America’s most popular import label: Corona. Antitrust concerns have come to light since the buyout was announced in June, as A-B could essentially see huge profits unhindered by competition. The deal is also under pressure by strict merger laws in the current administration, and by opposition from smaller competitors, who are able to gain the regulator’s support. The upcoming election is probably going to be the biggest impediment to the deal, and might even dampen A-B InBev’s enthusiasm for winning full control of Corona.
Full Content: St. Louis Post-Dispatch
Related Content: The Canadian Competition Bureau’s Attempt to Halt Beer Merger Goes Flat
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
CVS Health Explores Potential Breakup Amid Investor Pressure: Report
Oct 3, 2024 by
CPI
DirecTV Acquires Dish TV, Creating 20 Million-Subscriber Powerhouse
Oct 3, 2024 by
CPI
South Korea Fines Kakao Mobility $54.8 Million for Anti-Competitive Practices
Oct 3, 2024 by
CPI
Google Offers Settlement in India’s Antitrust Case Regarding Smart TVs
Oct 3, 2024 by
CPI
Attorney Challenges NCAA’s $2.78 Billion Settlement in Landmark Antitrust Cases
Oct 3, 2024 by
nhoch@pymnts.com
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh